Form 4: Myriad Genetics Chief Accounting Officer Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Natalie Munk, Chief Accounting Officer of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 6, 2024, Natalie Munk, the Chief Accounting Officer of Myriad Genetics Inc., reported a transaction involving the withholding of 581 shares of common stock.
- The shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $20.26.
- Following the transaction, Munk directly owns 44,440 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine transaction related to executive compensation and tax obligations.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 04/06/2024 | Date of the stock transaction (tax withholding). |
| 04/05/2024 | Date used to determine the closing price of Myriad common stock for tax withholding. |
| 04/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.